Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA WOCKHARDT AJANTA PHARMA/
WOCKHARDT
 
P/E (TTM) x 38.3 -16.8 - View Chart
P/BV x 8.3 2.7 310.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   WOCKHARDT
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
WOCKHARDT
Mar-23
AJANTA PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,426316 451.9%   
Low Rs1,062145 730.8%   
Sales per share (Unadj.) Rs297.2184.0 161.6%  
Earnings per share (Unadj.) Rs46.7-43.1 -108.4%  
Cash flow per share (Unadj.) Rs57.1-25.7 -222.3%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.1231.7 116.1%  
Shares outstanding (eoy) m125.91144.09 87.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.3 334.2%   
Avg P/E ratio x26.6-5.3 -498.3%  
P/CF ratio (eoy) x21.8-9.0 -242.9%  
Price / Book Value ratio x4.61.0 464.9%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63833,202 471.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8516,370 123.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42626,510 141.2%  
Other income Rs m9861,220 80.9%   
Total revenues Rs m38,41327,730 138.5%   
Gross profit Rs m7,833-1,930 -405.8%  
Depreciation Rs m1,3082,510 52.1%   
Interest Rs m583,020 1.9%   
Profit before tax Rs m7,453-6,240 -119.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573-30 -5,242.3%   
Profit after tax Rs m5,880-6,210 -94.7%  
Gross profit margin %20.9-7.3 -287.5%  
Effective tax rate %21.10.5 4,389.4%   
Net profit margin %15.7-23.4 -67.1%  
BALANCE SHEET DATA
Current assets Rs m28,25219,140 147.6%   
Current liabilities Rs m11,39334,350 33.2%   
Net working cap to sales %45.0-57.4 -78.5%  
Current ratio x2.50.6 445.0%  
Inventory Days Days6639 167.2%  
Debtors Days Days1011 93.9%  
Net fixed assets Rs m18,70748,670 38.4%   
Share capital Rs m253720 35.1%   
"Free" reserves Rs m33,62432,660 103.0%   
Net worth Rs m33,87733,380 101.5%   
Long term debt Rs m132,240 0.6%   
Total assets Rs m47,04770,750 66.5%  
Interest coverage x128.6-1.1 -12,062.3%   
Debt to equity ratio x00.1 0.5%  
Sales to assets ratio x0.80.4 212.3%   
Return on assets %12.6-4.5 -279.9%  
Return on equity %17.4-18.6 -93.3%  
Return on capital %22.2-9.0 -245.2%  
Exports to sales %59.90-   
Imports to sales %11.53.5 330.5%   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,293920 466.6%   
Fx inflow Rs m22,420730 3,071.3%   
Fx outflow Rs m4,293920 466.6%   
Net fx Rs m18,127-190 -9,540.6%   
CASH FLOW
From Operations Rs m7,9181,530 517.5%  
From Investments Rs m-5,596-1,250 447.7%  
From Financial Activity Rs m-1,079-3,150 34.2%  
Net Cashflow Rs m1,243-2,800 -44.4%  

Share Holding

Indian Promoters % 66.2 54.9 120.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 4.5 575.4%  
FIIs % 9.1 4.2 218.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 45.1 75.0%  
Shareholders   54,351 161,813 33.6%  
Pledged promoter(s) holding % 12.3 74.5 16.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Wockhardt Share Price Performance

Period AJANTA PHARMA Wockhardt S&P BSE HEALTHCARE
1-Day 2.51% 4.99% 1.18%
1-Month 7.60% 0.15% -0.75%
1-Year 92.91% 290.07% 61.82%
3-Year CAGR 21.63% 13.79% 18.16%
5-Year CAGR 26.85% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.